Latest filing published 25 Oct 2017 for Widepoint CORP, €18k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -43.9%Entry US$14.80 · Close at T+365 US$8.30
- +21.0%Entry US$15.70 · Close at T+365 US$19.00
- +71.2%Entry US$5.20 · Close at T+365 US$8.90
- +62.9%Entry US$3.50 · Close at T+365 US$5.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James T. Mccubbin: trading record in brief
James T. Mccubbin discloses dealings in 2 companies, chiefly Widepoint Corp and ProPhase Labs, Inc. In total, 37 filings cover trades dated from 12 April 2006 to 23 October 2017.
The open-market side counts 7 purchases for €25k alongside 10 sales for €733k. Netting one side against the other leaves €708k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 15 share grants and 5 option exercises.
Half of the purchases are above €3,886 and half below. Looking at 7 purchases old enough to measure, the stock rose over the following 90 days in 29% of cases; the median change was -19.2%. This is a record of the past, not a forecast.
The newest entry dates from 25 October 2017: a share grant of €18k, in Widepoint Corp. The last purchase on record was published on 1 December 2014, which is 4,361 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James T. Mccubbin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,250 shares@ US$0.5310.0% of flowCommon StockSEC:0001140361-17-039546:0
- 66,513 shares@ US$0.779727.6% of flowCommon StockSEC:0001140361-16-090580:0
- 63,487 shares@ US$0.760625.7% of flowCommon StockSEC:0001140361-16-090580:1
- 20,000 shares@ US$0.758.0% of flowCommon StockSEC:0001140361-16-090580:2
- 40,562 shares@ US$0.6713.7% of flowCommon StockSEC:0001140361-16-062090:0
- 40,562 shares@ US$0.7415.1% of flowCommon StockSEC:0001140361-16-061951:0
- 3,147 shares0Common Stock, par value $0.0005SEC:0001144204-15-000657:0
- 5,000 shares@ US$1.44Common StockSEC:0001140361-14-043755:0Canonical exit: 24 Feb 2015 (T+90)
- 2,745 shares0Common Stock, par value $0.0005SEC:0001144204-13-039595:0
- 834 shares@ US$1.55Common Stock, par value $0.0005SEC:0001144204-12-065903:0Canonical exit: 28 Feb 2013 (T+90)
- 10,000 shares@ US$0.48Common StockSEC:0001140361-12-038127:0Canonical exit: 18 Nov 2012 (T+90)
- 10,000 shares@ US$0.5147Common StockSEC:0001140361-12-038127:1Canonical exit: 19 Nov 2012 (T+90)
- 5,640 shares0Common Stock, par value $0.0005SEC:0001144204-11-057312:0
- 5,460 shares0Common Stock, par value $0.0005SEC:0001144204-11-040566:0
- 3,620 shares0Common Stock, par value $0.0005SEC:0001144204-11-023377:0
- 3,590 shares0Common Stock, par value $0.0005SEC:0001144204-11-005069:0
- 250,000 shares0Common StockSEC:0001140361-10-046617:0
- 100,000 shares@ US$0.17Common StockSEC:0001140361-10-046617:1
- 25,000 shares@ US$1.22Common StockSEC:0001140361-10-046617:2
- 3,533 shares0Common Stock, par value $0.0005SEC:0001144204-10-062142:0
- 350,000 shares@ US$0.17Common StockSEC:0001140361-10-040607:0
- 105,291 shares@ US$1.19Common StockSEC:0001140361-10-040607:1
- 169,709 shares@ US$1.24Common StockSEC:0001140361-10-040607:2
- 3,260 shares0Common Stock, par value $0.0005SEC:0001144204-10-037433:0
- 199,800 shares@ US$0.75Common StockSEC:0000897069-10-000257:0
25 of 34 declarations